332 related articles for article (PubMed ID: 29080987)
21. Selective CT for PET/CT: dose reduction in Langerhans cell histiocytosis.
Gelfand MJ; Sharp SE; Palumbo JS
Pediatr Radiol; 2015 Jan; 45(1):81-5. PubMed ID: 25149158
[TBL] [Abstract][Full Text] [Related]
22. Can full-dose contrast-enhanced CT be omitted from an FDG-PET/CT staging examination in newly diagnosed FDG-avid lymphoma?
van Hamersvelt HP; Kwee TC; Fijnheer R; Beek FJ; de Klerk JM; Nievelstein RA
J Comput Assist Tomogr; 2014; 38(4):620-5. PubMed ID: 24681861
[TBL] [Abstract][Full Text] [Related]
23. Radiation Dosimetry of Whole-Body Dual-Tracer 18F-FDG and 11C-Acetate PET/CT for Hepatocellular Carcinoma.
Liu D; Khong PL; Gao Y; Mahmood U; Quinn B; St Germain J; Xu XG; Dauer LT
J Nucl Med; 2016 Jun; 57(6):907-12. PubMed ID: 26823568
[TBL] [Abstract][Full Text] [Related]
24. An Australian local diagnostic reference level for paediatric whole-body
Alkhybari EM; McEntee MF; Willowson KP; Brennan PC; Kitsos T; Kench PL
Br J Radiol; 2019 Apr; 92(1096):20180879. PubMed ID: 30653334
[TBL] [Abstract][Full Text] [Related]
25. Noninvasive assessment of pediatric inflammatory bowel disease with ¹⁸F-fluorodeoxyglucose-positron emission tomography and computed tomography.
Däbritz J; Jasper N; Loeffler M; Weckesser M; Foell D
Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):81-9. PubMed ID: 21042220
[TBL] [Abstract][Full Text] [Related]
26. Direct comparison of FDG PET and CT findings in patients with lymphoma: initial experience.
Tatsumi M; Cohade C; Nakamoto Y; Fishman EK; Wahl RL
Radiology; 2005 Dec; 237(3):1038-45. PubMed ID: 16304117
[TBL] [Abstract][Full Text] [Related]
27. Novel weight-based dose threshold for 18F-NaF PET-CT imaging using advanced PET-CT systems: a potential tool for reducing radiation burden.
Marafi F; Esmail A; Rasheed R; Alkandari F; Usmani S
Nucl Med Commun; 2017 Sep; 38(9):764-770. PubMed ID: 28723715
[TBL] [Abstract][Full Text] [Related]
28. Feasibility of a multimodal (18)F-FDG-directed lymph node surgical excisional biopsy approach for appropriate diagnostic tissue sampling in patients with suspected lymphoma.
Povoski SP; Hall NC; Murrey DA; Wright CL; Martin EW
BMC Cancer; 2015 May; 15():378. PubMed ID: 25953144
[TBL] [Abstract][Full Text] [Related]
29. Patient-adapted organ absorbed dose and effective dose estimates in pediatric 18F-FDG positron emission tomography/computed tomography studies.
Quinn BM; Gao Y; Mahmood U; Pandit-Taskar N; Behr G; Zanzonico P; Dauer LT
BMC Med Imaging; 2020 Jan; 20(1):9. PubMed ID: 31996149
[TBL] [Abstract][Full Text] [Related]
30. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
[TBL] [Abstract][Full Text] [Related]
31. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
Moog F; Bangerter M; Diederichs CG; Guhlmann A; Kotzerke J; Merkle E; Kolokythas O; Herrmann F; Reske SN
Radiology; 1997 Jun; 203(3):795-800. PubMed ID: 9169707
[TBL] [Abstract][Full Text] [Related]
32. [¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies.
Terezakis SA; Hunt MA; Kowalski A; McCann P; Schmidtlein CR; Reiner A; Gönen M; Kirov AS; Gonzales AM; Schöder H; Yahalom J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):615-22. PubMed ID: 20933343
[TBL] [Abstract][Full Text] [Related]
33. [Investigation of Computed Tomography Exposure Dose for Whole-body
Maeda Y; Taniguchi Y; Takauchi K; Kageyama S; Kangai Y; Kenda S
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2019; 75(1):62-67. PubMed ID: 30662034
[TBL] [Abstract][Full Text] [Related]
34. [Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison].
Bumann D; de Wit M; Beyer W; Beese M; Lübeck M; Bücheler E; Clausen M
Rofo; 1998 May; 168(5):457-65. PubMed ID: 9617362
[TBL] [Abstract][Full Text] [Related]
35. The clinical impact of
Hart A; Vali R; Marie E; Shaikh F; Shammas A
Pediatr Radiol; 2017 Oct; 47(11):1508-1513. PubMed ID: 28664453
[TBL] [Abstract][Full Text] [Related]
36. Defining optimal tracer activities in pediatric oncologic whole-body
Gatidis S; Schmidt H; la Fougère C; Nikolaou K; Schwenzer NF; Schäfer JF
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2283-2289. PubMed ID: 27565153
[TBL] [Abstract][Full Text] [Related]
37. EFFECTIVE RADIATION DOSE OF 18F-FDG PET/CT: HOW MUCH DOES DIAGNOSTIC CT CONTRIBUTE?
Li Y; Jiang L; Wang H; Cai H; Xiang Y; Li L
Radiat Prot Dosimetry; 2019 Dec; 187(2):183-190. PubMed ID: 31147708
[TBL] [Abstract][Full Text] [Related]
38. Optimization of the CT acquisition protocol to reduce patient dose without compromising the diagnostic quality for PET-CT: a phantom study.
Kumar S; Pandey AK; Sharma P; Malhotra A; Kumar R
Nucl Med Commun; 2012 Feb; 33(2):164-70. PubMed ID: 22107995
[TBL] [Abstract][Full Text] [Related]
39.
Ram-Wolff C; Vercellino L; Brice P; La Selva R; Bagot M
Eur J Dermatol; 2017 Oct; 27(5):496-504. PubMed ID: 28721937
[TBL] [Abstract][Full Text] [Related]
40. Clinical evaluation of reconstruction and acquisition time for pediatric
Shkumat NA; Vali R; Shammas A
Pediatr Radiol; 2020 Jun; 50(7):966-972. PubMed ID: 32125447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
